Business Wire

CA-VISA

16.11.2022 14:01:50 CET | Business Wire | Press release

Share
Think You Know How to Spot a Scam? New Visa Report Finds That Even Savvy Consumers Get Tripped Up by the Language of Fraud

It's not your imagination. Digital scams are everywhere in our daily lives. And as the holiday season approaches, fraudsters are counting on you to let your guard down and take the bait. Whether in the workplace or on the go, we're peppered by phone, text and email with offers for "free gifts" and traps to "act now" to supply personal information before a vital service gets cut off. And this barrage of “fraudulese” is working.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221116005258/en/

A new research report out today from Visa (NYSE: V), in partnership with Wakefield Research, “Fraudulese: The Language of Fraud,” brings to light that when it comes to spotting scams, cybercriminals are finding vulnerabilities among even the most tech-savvy consumers. While nearly half of the population are confident they can recognize a scam, 73% are likely to miss the requisite red flags in digital communications.

From a spoofed service notification from your electric company, to an email alerting you that you’ve won products from your favorite store, or even job postings that make it seem like you’ve been hired by a top-tier company, scams hit almost every touchpoint in our digital lives. In the last year alone, Visa has proactively blocked $7.2 billion in attempted fraudulent payments across 122 million transactions before those transactions impacted clients.

“Understanding the language of fraud is increasingly essential in our digital-first world. Scammers have reached new heights of sophistication in both language and variety – no one is immune,” said Paul Fabara, Chief Risk Officer, Visa. “Education around the language of scams is an integral part of our consumer protection, and highlighting the commonalities in the language of fraud helps prevent crime globally.”

Earlier this year as part of Visa’s efforts to empower consumers to learn about the language of fraud, the company commissioned a first-of-its-kind linguistic analysis by researchers in the U.K. revealing how language can be used by fraudsters in short messages. The study revealed that solutions inviting consumers to engage with a problem or offer are the most common fraudulent message, occurring in 87% of the scam text messages, while problem statements that provoke action from the recipient were the second most common.

“By highlighting the communicative strategies, words and phrases used by fraudsters, we hope people can more easily spot the language of fraud as it stands today, which ultimately helps to protect them,” said Dr. Marton Petyko, from the Aston Institute for Forensic Linguistics, which conducted the U.K. research.

Exploring The Language of Fraud: A Disconnect Between Awareness and Action

Falling victim to cyber fraud is costly. In 2021, the FBI’s Internet Crime Complaint Center reported a record number of complaints, with potential losses exceeding $6.9 billion, up from $4.1 billion in 2020.

According to Visa’s new report, which surveyed 6,000 adults in 18 markets worldwide, scammers appear to be thriving in the gap between consumers’ awareness of the language of fraud and their actual behavior. Among the top findings:

  • We think others are more susceptible to fraud than we are. While consumers feel confident in their own vigilance, the vast majority (90%) are concerned that friends or family members may fall for potential scams that include emails or text messages asking people to verify their account information, asking about overdrawn banking accounts and notifying them about winning a gift card or product from an online shopping site.

    The most enticing clickbait messages capitalize on consumer excitement, and fraudulently tout “winning,” “exclusive deals” or “free gift,” the survey found.
  • Is it legitimate? More than 4 in 5 (81%) respondents check the wrong details to determine the authenticity of a communication, focusing on features scammers can easily fake, including the company’s name or logo (46%). Individuals can better protect themselves from fraudsters by checking details that are harder to fake, such as account numbers or details about their interactions with the company.
  • Overlooking telltale signs. Only 60% of people reported looking to ensure a communication is sent from a valid email address. Fewer than half (47%) look to ensure words are spelled properly.
  • Crypto users proceed with caution. Crypto users are more likely to identify the right kind of verifying elements of a potential scam than non-crypto owners. For example, they are more likely to check their account information (49% vs 37%) to confirm the validity of digital communications.

Take a Few Extra Moments to Decipher Fraudulese

Consumers can better protect themselves by taking a few extra moments before clicking, including taking time to understand the way fraudsters use language. Among simple, but effective best practices: Keep personal information to yourself. Don’t click on links before verifying they’ll take you where they say they will. Turn on purchase alerts, which provide near real-time notification by text message or email of purchases made with your account. Call the number on corporate websites or the back of your credit and debit cards if you are unsure if a communication is valid – don't just call the number possibly provided by the scammer in their text or email.

Protection Is Visa’s Top Priority

While cybercrime persists in an increasingly digital world, Visa is mission-driven to protect consumers and mitigate fraud. Over the past five years, the company has invested more than $10 billion in technology, including to reduce fraud and increase network security. More than a thousand dedicated specialists protect Visa’s network from malware, zero-day attacks and insider threats 24x7x365. In fact, over the last 12 months, Visa’s real-time monitoring has proactively blocked over $7.2 billion in fraudulent payments, preventing many from ever knowing they were at risk of a potential fraudulent transaction. Learn more at visa.com/security.

About Visa

Visa Inc. (NYSE: V) is the world’s leader in digital payments. Our mission is to connect the world through the most innovative, reliable and secure payment network - enabling individuals, businesses and economies to thrive. Our advanced global processing network, VisaNet, provides secure and reliable payments around the world, and is capable of handling more than 65,000 transaction messages a second. The company’s relentless focus on innovation is a catalyst for the rapid growth of digital commerce on any device for everyone, everywhere. As the world moves from analog to digital, Visa is applying our brand, products, people, network and scale to reshape the future of commerce. For more information, visit About Visa, visa.com/blog and @VisaNews.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221116005258/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye